Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.3.2022Pfizer Europe MA EEIG (PFI-BE-3)8199CVFEND 200 mg filmom obalené tablety (tbl flm 14x200 mg (blis.PVC/Al/PVC/PVDC))18.3.2022O
 17.3.2022Teva B.V. (TEV-NL-4)76401Sorbimon 20 mg (tbl 50x20 mg)25.3.2022O
 17.3.2022Teva B.V. (TEV-NL-4)76402Sorbimon 20 mg (tbl 100x20 mg)25.3.2022O
 17.3.2022Teva B.V. (TEV-NL-4)91386Gabapentin-Teva 400 mg (cps dur 200(2x100)x400 mg (blis.PVC/PVDC/Al))25.3.2022O
 17.3.2022Zentiva, k.s. (ZNT-1)75433CHLORPROTHIXEN 15 LÉČIVA (tbl flm 30x15 mg (blis.PVC/Al))20.5.2022R
 17.3.2022ratiopharm GmbH (RAT)21691Candesartan ratiopharm 16 mg (tbl 28x16 mg (blis.PVC/PVDC/Al))25.3.2022O
 17.3.2022ratiopharm GmbH (RAT)35324Perindopril-ratiopharm 4 mg (tbl 90x4 mg (blis.PVC/PE/PVDC/Al))18.3.2022O
 17.3.2022ratiopharm GmbH (RAT)37703Moxonidin-ratiopharm 0,3 mg (tbl flm 100x0,3 mg (blis.PVC/PVDC/Al))25.3.2022O
 16.3.2022CHEPLAPHARM Arzneimittel GmbH (CEP-1)89771Ebrantil 60 (cps pld 50x60 mg (fľ.HDPE))17.3.2022R
 16.3.2022KRKA, d.d., Novo mesto (KRK-2)4390CBetaklav 875 mg/125 mg filmom obalené tablety (tbl flm 14x875 mg/125 mg (blis.OPA/Al/PVC/Al))21.3.2022O
 16.3.2022KRKA, d.d., Novo mesto (KRK-2)45300Azibiot (tbl flm 3x500 mg)21.3.2022O
 16.3.2022Bayer, spol. s r.o. (BAY-SK-2)31893Iberogast (sol por 1x20 ml (fľ.skl.hnedá))16.3.2022O
 16.3.2022Mylan IRE Healthcare Limited (MYR)62402Fraxiparine 7 600 IU (anti Xa)/0,8 ml (sol inj 10x0,8 ml/7,6 KU (striek.inj.skl.napl.))21.3.2022R
 16.3.2022Mylan IRE Healthcare Limited (MYR)96988Fraxiparine 9 500 IU (anti-Xa)/1 ml (sol inj 10x1 ml/9,5 KU (striek.inj.skl.napl.))21.3.2022R
 15.3.2022Zentiva, k.s. (ZNT-1)13556Agen 5 (tbl 30x5 mg (blis. PVC/PVDC/Al))15.3.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To